Agmatine-attenuated cognitive and social deficits in subchronic MK-801 model of schizophrenia in rats

A-582941, cholinergic alpha 7 nicotinic receptor agonist, improved cognitive and negative symptoms of the sub-chronic MK-801 model of schizophrenia in rats

(2017) Gokhan Unal et al.   Psychiatry and Clinical Psychopharmacology

Agmatine attenuates reserpine-induced oral dyskinesia in mice: Role of oxidative stress, nitric oxide and glutamate NMDA receptors

(2016) Andréia S. Cunha et al.   BEHAVIOURAL BRAIN RESEARCH

Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology

(2016) Jo C. Neill et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Neurobiological Basis of Insight in Schizophrenia

(2016) Rose Mary Xavier et al.   NURSING RESEARCH

Altered brain arginine metabolism in schizophrenia

(2016) P Liu et al.   Translational Psychiatry

The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia

(2014) Lakshmi Rajagopal et al.   CURRENT PHARMACEUTICAL DESIGN

Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt/GSK3β signaling disruption

(2014) Maryam Moosavi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment

(2014) Mark J. Millan et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Agmatine Improves Cognitive Dysfunction and Prevents Cell Death in a Streptozotocin-Induced Alzheimer Rat Model

(2014) Juhyun Song et al.   YONSEI MEDICAL JOURNAL

Agmatine: clinical applications after 100 years in translation

(2013) John E. Piletz et al.   DRUG DISCOVERY TODAY

Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: A translational link to humans

(2013) Joanna C. Neill et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Agmatine, a metabolite of L-arginine, reverses scopolamine-induced learning and memory impairment in rats

(2012) Tijen Utkan et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

One-trial object recognition in rats and mice: Methodological and theoretical issues

(2010) A. Ennaceur   BEHAVIOURAL BRAIN RESEARCH

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism

(2010) Joanna C. Neill et al.   PHARMACOLOGY & THERAPEUTICS

Translational Aspects of the Novel Object Recognition Task in Rats Abstinent Following Sub-Chronic Treatment with Phencyclidine (PCP): Effects of Modafinil and Relevance to Cognitive Deficits in Schizophrenia

(2010) John P. Redrobe et al.   Frontiers in Psychiatry

Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats

(2009) T. Uzbay et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Differential effects of i.c.v. microinfusion of agmatine on spatial working and reference memory in the rat

(2009) P. Liu et al.   NEUROSCIENCE

Agmatine attenuates the disruptive effects of phencyclidine on prepulse inhibition

(2008) Erik Pålsson et al.   EUROPEAN JOURNAL OF PHARMACOLOGY